Svejda J, Lorenz I
Neoplasma. 1985;32(4):495-8.
Forty-five thousand three hundred thirteen patients treated in our Institute during the period 1949-1982 were retrospectively analyzed in regard to the appearance of secondary tumors after therapy. Eighty-seven (0.19%) tumors were found, 71 (81.6%) being secondary and 16 (18.4%) simultaneous. Fifty-one (71.8%) tumors were lymphoid, 20 (28.1%) nonlymphoid. Thirty-seven (52.1%) tumors appeared after radiotherapy, 13 (18.3%) after chemotherapy alone. Secondary tumors appeared mostly after 6 years. The prevalence of lymphoid secondary tumors may be explained as a compensatory proliferation of surviving cells progressing to neoplasia. Cytostatics and ionizing radiation as both the initiators and the promoters of malignancy, have besides person's susceptibility a triggering function. From these aspects before any treatment is started all possible carcinogenic factors should be taken into consideration and less carcinogenic procedures with keeping up a full effectiveness should be chosen.
对1949年至1982年期间在我院接受治疗的45313例患者进行回顾性分析,以研究治疗后继发性肿瘤的出现情况。共发现87例肿瘤(0.19%),其中71例(81.6%)为继发性肿瘤,16例(18.4%)为同时性肿瘤。51例(71.8%)肿瘤为淋巴样肿瘤,20例(28.1%)为非淋巴样肿瘤。37例(52.1%)肿瘤出现在放疗后,13例(18.3%)仅出现在化疗后。继发性肿瘤大多在6年后出现。淋巴样继发性肿瘤的高发可能解释为存活细胞的代偿性增殖发展为肿瘤形成。细胞抑制剂和电离辐射既是恶性肿瘤的引发剂又是促进剂,除了个体易感性外还具有触发作用。从这些方面来看,在开始任何治疗之前,都应考虑所有可能的致癌因素,并选择致癌性较小但能保持充分疗效的治疗方法。